News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioAxone Therapeutic Inc. Announces A Second-Round Investment Of $12.15 Million


10/19/2005 5:09:54 PM

MONTREAL, May 19 /CNW Telbec/ - BioAxone Therapeutic Inc., a Montreal- based neuroscience company, is pleased to announce the recent closing of a second-round investment of $12.15 M. Four major venture capital companies, namely T2C2/Bio2000, Solidarity Fund QFL, Investissement Desjardins and Lothian Partners 27 SARL, made the investment.

Read at Canada NewsWire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES